Perrigo Receives Binding Offer to Divest its HRA Pharma Rare Diseases Business for up to 275 Million Perrigo Receives Binding Offer to Divest its HRA Pharma Rare Diseases Business for up to 275...
StockNews.com upgraded shares of Perrigo (NYSE:PRGO - Free Report) from a hold rating to a buy rating in a report issued on Wednesday morning.
Separately, JPMorgan Chase & Co. dropped their target...
Patriot Financial Group Insurance Agency LLC grew its holdings in shares of Perrigo Company plc (NYSE:PRGO - Free Report) by 4.1% in the fourth quarter, according to its most recent filing with the...
A month has gone by since the last earnings report for Perrigo (PRGO). Shares have added about 19.1% in that time frame, outperforming the S&P 500.Will the recent positive trend continue leading up...
Teachers Retirement System of The State of Kentucky raised its stake in shares of Perrigo Company plc (NYSE:PRGO Free Report) by 94.1% during the 3rd quarter, according to its most recent...
A closer look at one of the leaders in the global over-the-counter pharmaceuticals marketRelated Stocks: PRGO, SPY, TEVA, PFE, ABBV, GSK, WBA, AMZN, CVS, WMT, HLN, RDY...
Neo Ivy Capital Management lowered its stake in Perrigo Company plc (NYSE:PRGO Free Report) by 66.1% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The...
Investors in Perrigo Company plc (PRGO) saw new options become available today, for the November 15th expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is...